Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2017

Open Access 01-12-2017 | Study protocol

Better Indigenous Risk stratification for Cardiac Health study (BIRCH) protocol: rationale and design of a cross-sectional and prospective cohort study to identify novel cardiovascular risk indicators in Aboriginal Australian and Torres Strait Islander adults

Authors: Marc G. W. Rémond, Simon Stewart, Melinda J. Carrington, Thomas H. Marwick, Bronwyn A. Kingwell, Peter Meikle, Darren O’Brien, Nathaniel S. Marshall, Graeme P. Maguire

Published in: BMC Cardiovascular Disorders | Issue 1/2017

Login to get access

Abstract

Background

Of the estimated 10–11 year life expectancy gap between Indigenous (Aboriginal and Torres Strait Islander people) and non-Indigenous Australians, approximately one quarter is attributable to cardiovascular disease (CVD). Risk prediction of CVD is imperfect, but particularly limited for Indigenous Australians. The BIRCH (Better Indigenous Risk stratification for Cardiac Health) project aims to identify and assess existing and novel markers of early disease and risk in Indigenous Australians to optimise health outcomes in this disadvantaged population. It further aims to determine whether these markers are relevant in non-Indigenous Australians.

Methods/design

BIRCH is a cross-sectional and prospective cohort study of Indigenous and non-Indigenous Australian adults (≥ 18 years) living in remote, regional and urban locations. Participants will be assessed for CVD risk factors, left ventricular mass and strain via echocardiography, sleep disordered breathing and quality via home-based polysomnography or actigraphy respectively, and plasma lipidomic profiles via mass spectrometry. Outcome data will comprise CVD events and death over a period of five years.

Discussion

Results of BIRCH may increase understanding regarding the factors underlying the increased burden of CVD in Indigenous Australians in this setting. Further, it may identify novel markers of early disease and risk to inform the development of more accurate prediction equations. Better identification of at-risk individuals will promote more effective primary and secondary preventive initiatives to reduce Indigenous Australian health disadvantage.
Literature
1.
go back to reference Australian Institute of Health and Welfare. The health and welfare of Australia’s Aboriginal and Torres Strait Islander peoples, an overview 2011. AIHW Cat. No. IHW 42. Canberra: AIHW; 2011. Australian Institute of Health and Welfare. The health and welfare of Australia’s Aboriginal and Torres Strait Islander peoples, an overview 2011. AIHW Cat. No. IHW 42. Canberra: AIHW; 2011.
2.
go back to reference Vos T, Barker B, Begg S, Stanley L, Lopez AD. Burden of disease and injury in Aboriginal and Torres Strait islander peoples: the Indigenous health gap. Int J Epidemiol. 2009;38:470–7. Vos T, Barker B, Begg S, Stanley L, Lopez AD. Burden of disease and injury in Aboriginal and Torres Strait islander peoples: the Indigenous health gap. Int J Epidemiol. 2009;38:470–7.
3.
go back to reference Australian Institute of Health and Welfare. Heart, stroke and vascular diseases—Australian facts 2004. Cardiovascular Disease Series No. 22. AIHW Cat. No. CVD 27. Canberra: AIHW and National Heart Foundation of Australia; 2004. Australian Institute of Health and Welfare. Heart, stroke and vascular diseases—Australian facts 2004. Cardiovascular Disease Series No. 22. AIHW Cat. No. CVD 27. Canberra: AIHW and National Heart Foundation of Australia; 2004.
4.
go back to reference Australian Institute of Health and Welfare, Penm E. Cardiovascular disease and its associated risk factors in Aboriginal and Torres Strait Islander peoples 2004–05. Cardiovascular disease series no. 29. Cat. No. CVD 41. Canberra: AIHW; 2008. Australian Institute of Health and Welfare, Penm E. Cardiovascular disease and its associated risk factors in Aboriginal and Torres Strait Islander peoples 2004–05. Cardiovascular disease series no. 29. Cat. No. CVD 41. Canberra: AIHW; 2008.
5.
go back to reference McGrady M, Krum H, Carrington MJ, Stewart S, Zeitz C, Lee GA, Marwick TH,et al. Heart failure, ventricular dysfunction and risk factor prevalence in Australian Aboriginal peoples: the heart of the heart study. Heart. 2012;98:1562–7. McGrady M, Krum H, Carrington MJ, Stewart S, Zeitz C, Lee GA, Marwick TH,et al. Heart failure, ventricular dysfunction and risk factor prevalence in Australian Aboriginal peoples: the heart of the heart study. Heart. 2012;98:1562–7.
6.
7.
go back to reference Simmonds MC, Wald NJ. Risk estimation versus screening performance: a comparison of six risk algorithms for cardiovascular disease. J Med Screen. 2012;19:201–5.CrossRefPubMed Simmonds MC, Wald NJ. Risk estimation versus screening performance: a comparison of six risk algorithms for cardiovascular disease. J Med Screen. 2012;19:201–5.CrossRefPubMed
8.
go back to reference Bjornson E, Boren J, Mardinoglu A. Personalized cardiovascular disease prediction and treatment - a review of existing strategies and novel systems medicine tools. Front Physiol. 2016;7:2.CrossRefPubMedPubMedCentral Bjornson E, Boren J, Mardinoglu A. Personalized cardiovascular disease prediction and treatment - a review of existing strategies and novel systems medicine tools. Front Physiol. 2016;7:2.CrossRefPubMedPubMedCentral
9.
go back to reference Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.CrossRefPubMed Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.CrossRefPubMed
10.
go back to reference Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293–8.CrossRefPubMed Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293–8.CrossRefPubMed
11.
go back to reference D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation. 2008;117:743–53.CrossRefPubMed D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation. 2008;117:743–53.CrossRefPubMed
12.
go back to reference Wang Z, Hoy WE. Cardiovascular risk among urban Aboriginal people. Med J Aust. 2003;179:557. Wang Z, Hoy WE. Cardiovascular risk among urban Aboriginal people. Med J Aust. 2003;179:557.
13.
go back to reference Wang Z, Hoy WE. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Med J Aust. 2005;182:66–9. Wang Z, Hoy WE. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Med J Aust. 2005;182:66–9.
14.
go back to reference Wang Z, Hoy WE. Waist circumference, body mass index, hip circumference and waist-to-hip ratio as predictors of cardiovascular disease in Aboriginal people. Eur J Clin Nutr. 2004;58:888–93. Wang Z, Hoy WE. Waist circumference, body mass index, hip circumference and waist-to-hip ratio as predictors of cardiovascular disease in Aboriginal people. Eur J Clin Nutr. 2004;58:888–93.
15.
go back to reference Wang Z, Hoy WE. C-reactive protein: an independent predictor of cardiovascular disease in Aboriginal Australians. Aust N Z J Public Health. 2010;34(Suppl 1):S25–9. Wang Z, Hoy WE. C-reactive protein: an independent predictor of cardiovascular disease in Aboriginal Australians. Aust N Z J Public Health. 2010;34(Suppl 1):S25–9.
16.
go back to reference McDermott RA, McCulloch B, Li M. Glycaemia and albuminuria as predictors of coronary heart disease in Aboriginal and Torres Strait Islander adults: a north Queensland cohort. Med J Aust. 2011;194:514–8. McDermott RA, McCulloch B, Li M. Glycaemia and albuminuria as predictors of coronary heart disease in Aboriginal and Torres Strait Islander adults: a north Queensland cohort. Med J Aust. 2011;194:514–8.
17.
go back to reference Luke JN, Brown AD, Brazionis L, O'Dea K, Best JD, McDermott RA, et al. Exploring clinical predictors of cardiovascular disease in a central Australian Aboriginal cohort. Eur J Prev Cardiol. 2013;20:246–53. Luke JN, Brown AD, Brazionis L, O'Dea K, Best JD, McDermott RA, et al. Exploring clinical predictors of cardiovascular disease in a central Australian Aboriginal cohort. Eur J Prev Cardiol. 2013;20:246–53.
19.
go back to reference Australian Institute of Health and Welfare. Better Cardiac Care measures for Aboriginal and Torres Strait Islander people: second national report 2016. Cat. No. IHW 169. Canberra: AIHW; 2016. Australian Institute of Health and Welfare. Better Cardiac Care measures for Aboriginal and Torres Strait Islander people: second national report 2016. Cat. No. IHW 169. Canberra: AIHW; 2016.
20.
go back to reference Bradshaw PJ, Alfonso HS, Finn J, Owen J, Thompson PL. A comparison of coronary heart disease event rates among urban Australian Aboriginal people and a matched non-Aboriginal population. J Epidemiol Community Health. 2011;65:315–9. Bradshaw PJ, Alfonso HS, Finn J, Owen J, Thompson PL. A comparison of coronary heart disease event rates among urban Australian Aboriginal people and a matched non-Aboriginal population. J Epidemiol Community Health. 2011;65:315–9.
21.
go back to reference Bradshaw PJ, Alfonso HS, Finn JC, Owen J, Thompson PL. Coronary heart disease events in Aboriginal Australians: incidence in an urban population. Med J Aust. 2009;190:583–6. Bradshaw PJ, Alfonso HS, Finn JC, Owen J, Thompson PL. Coronary heart disease events in Aboriginal Australians: incidence in an urban population. Med J Aust. 2009;190:583–6.
23.
go back to reference Russo I, Frangogiannis NG. Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities. J Mol Cell Cardiol. 2016;90:84–93.CrossRefPubMed Russo I, Frangogiannis NG. Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities. J Mol Cell Cardiol. 2016;90:84–93.CrossRefPubMed
24.
go back to reference Nagai M, Hoshide S, Kario K. Sleep duration as a risk factor for cardiovascular disease - a review of the recent literature. Curr Cardiol Rev. 2010;6:54–61.CrossRefPubMedPubMedCentral Nagai M, Hoshide S, Kario K. Sleep duration as a risk factor for cardiovascular disease - a review of the recent literature. Curr Cardiol Rev. 2010;6:54–61.CrossRefPubMedPubMedCentral
25.
go back to reference Chang JH, Huang PT, Lin YK, Lin CE, Lin CM, Shieh YH, et al. Association between sleep duration and sleep quality, and metabolic syndrome in Taiwanese police officers. Int J Occup Med Environ Health. 2015;28:1011–23.CrossRefPubMed Chang JH, Huang PT, Lin YK, Lin CE, Lin CM, Shieh YH, et al. Association between sleep duration and sleep quality, and metabolic syndrome in Taiwanese police officers. Int J Occup Med Environ Health. 2015;28:1011–23.CrossRefPubMed
26.
go back to reference Jay SM, Smith BP, Windler S, Dorrian J, Ferguson SA. Does suspected sleep disordered breathing impact on the sleep and performance of firefighting volunteers during a simulated fire ground campaign? Int J Environ Res Public Health. 2016;13:173.CrossRefPubMedPubMedCentral Jay SM, Smith BP, Windler S, Dorrian J, Ferguson SA. Does suspected sleep disordered breathing impact on the sleep and performance of firefighting volunteers during a simulated fire ground campaign? Int J Environ Res Public Health. 2016;13:173.CrossRefPubMedPubMedCentral
27.
go back to reference Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003;290:1906–14.CrossRefPubMed Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003;290:1906–14.CrossRefPubMed
28.
go back to reference Floras JS. Obstructive sleep apnea syndrome, continuous positive airway pressure and treatment of hypertension. Eur J Pharmacol. 2015;763:28–37.CrossRefPubMed Floras JS. Obstructive sleep apnea syndrome, continuous positive airway pressure and treatment of hypertension. Eur J Pharmacol. 2015;763:28–37.CrossRefPubMed
29.
go back to reference Gilat H, Vinker S, Buda I, Soudry E, Shani M, Bachar G. Obstructive sleep apnea and cardiovascular comorbidities: a large epidemiologic study. Medicine. 2014;93:e45.CrossRefPubMedPubMedCentral Gilat H, Vinker S, Buda I, Soudry E, Shani M, Bachar G. Obstructive sleep apnea and cardiovascular comorbidities: a large epidemiologic study. Medicine. 2014;93:e45.CrossRefPubMedPubMedCentral
30.
go back to reference Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O'Connor GT, Resnick HE, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med. 2010;182:269–77.CrossRefPubMedPubMedCentral Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O'Connor GT, Resnick HE, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med. 2010;182:269–77.CrossRefPubMedPubMedCentral
31.
go back to reference Marshall NS, Wong KK, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton health study cohort. J Clin Sleep Med. 2014;10:355–62.PubMedPubMedCentral Marshall NS, Wong KK, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton health study cohort. J Clin Sleep Med. 2014;10:355–62.PubMedPubMedCentral
32.
go back to reference Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005;172:1447–51.CrossRefPubMedPubMedCentral Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005;172:1447–51.CrossRefPubMedPubMedCentral
33.
go back to reference Woods CE, McPherson K, Tikoft E, Usher K, Hosseini F, Ferns J, et al. Sleep disorders in Aboriginal and Torres Strait Islander people and residents of regional and remote Australia. J Clin Sleep Med. 2015;11:1263–71. Woods CE, McPherson K, Tikoft E, Usher K, Hosseini F, Ferns J, et al. Sleep disorders in Aboriginal and Torres Strait Islander people and residents of regional and remote Australia. J Clin Sleep Med. 2015;11:1263–71.
34.
go back to reference St John Sutton M, Pfeffer MA, Moye L, Plappert T, Rouleau JL, Lamas G, et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation. 1997;96:3294–9.CrossRefPubMed St John Sutton M, Pfeffer MA, Moye L, Plappert T, Rouleau JL, Lamas G, et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation. 1997;96:3294–9.CrossRefPubMed
35.
go back to reference Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112:3738–44.CrossRefPubMed Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112:3738–44.CrossRefPubMed
36.
go back to reference Abebe TB, Gebreyohannes EA, Tefera YG, Abegaz TM. Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study. BMC Cardiovasc Disord. 2016;16:232.CrossRefPubMedPubMedCentral Abebe TB, Gebreyohannes EA, Tefera YG, Abegaz TM. Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study. BMC Cardiovasc Disord. 2016;16:232.CrossRefPubMedPubMedCentral
37.
go back to reference Krishnasamy R, Isbel NM, Hawley CM, Pascoe EM, Burrage M, Leano R, et al. Left ventricular global longitudinal strain (GLS) is a superior predictor of all-cause and cardiovascular mortality when compared to ejection fraction in advanced chronic kidney disease. PLoS One. 2015;10:e0127044.CrossRefPubMedPubMedCentral Krishnasamy R, Isbel NM, Hawley CM, Pascoe EM, Burrage M, Leano R, et al. Left ventricular global longitudinal strain (GLS) is a superior predictor of all-cause and cardiovascular mortality when compared to ejection fraction in advanced chronic kidney disease. PLoS One. 2015;10:e0127044.CrossRefPubMedPubMedCentral
38.
go back to reference Kalam K, Otahal P, Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart. 2014;100:1673–80.CrossRefPubMed Kalam K, Otahal P, Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart. 2014;100:1673–80.CrossRefPubMed
39.
go back to reference Stanton T, Leano R, Marwick TH. Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging. 2009;2:356–64.CrossRefPubMed Stanton T, Leano R, Marwick TH. Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging. 2009;2:356–64.CrossRefPubMed
40.
go back to reference Saito M, Negishi K, Eskandari M, Huynh Q, Hawson J, Moore A, et al. Association of left ventricular strain with 30-day mortality and readmission in patients with heart failure. J Am Soc Echocardiogr. 2015;28:652–66.CrossRefPubMed Saito M, Negishi K, Eskandari M, Huynh Q, Hawson J, Moore A, et al. Association of left ventricular strain with 30-day mortality and readmission in patients with heart failure. J Am Soc Echocardiogr. 2015;28:652–66.CrossRefPubMed
41.
go back to reference Heckbert SR, Post W, Pearson GD, Arnett DK, Gomes AS, Jerosch-Herold M, et al. Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the multiethnic study of atherosclerosis. J Am Coll Cardiol. 2006;48:2285–92.CrossRefPubMedPubMedCentral Heckbert SR, Post W, Pearson GD, Arnett DK, Gomes AS, Jerosch-Herold M, et al. Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the multiethnic study of atherosclerosis. J Am Coll Cardiol. 2006;48:2285–92.CrossRefPubMedPubMedCentral
42.
go back to reference Turakhia MP, Schiller NB, Whooley MA. Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the heart and soul study). Am J Cardiol. 2008;102:1131–5.CrossRefPubMedPubMedCentral Turakhia MP, Schiller NB, Whooley MA. Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the heart and soul study). Am J Cardiol. 2008;102:1131–5.CrossRefPubMedPubMedCentral
43.
go back to reference Le Heuzey JY, Guize L. Cardiac prognosis in hypertensive patients. Incidence of sudden death and ventricular arrhythmias. Am J Med. 1988;84:65–8.CrossRefPubMed Le Heuzey JY, Guize L. Cardiac prognosis in hypertensive patients. Incidence of sudden death and ventricular arrhythmias. Am J Med. 1988;84:65–8.CrossRefPubMed
44.
go back to reference Verdecchia P, Carini G, Circo A, Dovellini E, Giovannini E, Lombardo M, et al. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol. 2001;38:1829–35.CrossRefPubMed Verdecchia P, Carini G, Circo A, Dovellini E, Giovannini E, Lombardo M, et al. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol. 2001;38:1829–35.CrossRefPubMed
45.
go back to reference Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998;32:1454–9.CrossRefPubMed Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998;32:1454–9.CrossRefPubMed
46.
go back to reference Meikle PJ, Wong G, Barlow CK, Kingwell BA. Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease. Pharmacol Ther. 2014;143:12–23.CrossRefPubMed Meikle PJ, Wong G, Barlow CK, Kingwell BA. Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease. Pharmacol Ther. 2014;143:12–23.CrossRefPubMed
47.
go back to reference Meikle PJ, Wong G, Tsorotes D, Barlow CK, Weir JM, Christopher MJ, et al. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol. 2011;31:2723–32.CrossRefPubMed Meikle PJ, Wong G, Tsorotes D, Barlow CK, Weir JM, Christopher MJ, et al. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol. 2011;31:2723–32.CrossRefPubMed
49.
go back to reference Alshehry ZH, Mundra PA, Barlow CK, Mellett NA, Wong G, McConville MJ, et al. Plasma lipidomic profiles improve on traditional risk factors for the prediction of cardiovascular events in type 2 diabetes mellitus. Circulation. 2016;134:1637–50. Alshehry ZH, Mundra PA, Barlow CK, Mellett NA, Wong G, McConville MJ, et al. Plasma lipidomic profiles improve on traditional risk factors for the prediction of cardiovascular events in type 2 diabetes mellitus. Circulation. 2016;134:1637–50.
50.
go back to reference Stegemann C, Pechlaner R, Willeit P, Langley SR, Mangino M, Mayr U, et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation. 2014;129:1821–31.CrossRefPubMed Stegemann C, Pechlaner R, Willeit P, Langley SR, Mangino M, Mayr U, et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation. 2014;129:1821–31.CrossRefPubMed
51.
go back to reference Kingwell BA, Chapman MJ, Kontush A, Miller NE. HDL-targeted therapies: progress, failures and future. Nat Rev Drug Discov. 2014;13:445–64.CrossRefPubMed Kingwell BA, Chapman MJ, Kontush A, Miller NE. HDL-targeted therapies: progress, failures and future. Nat Rev Drug Discov. 2014;13:445–64.CrossRefPubMed
52.
go back to reference Turner T, Stein EA. Non-statin treatments for managing LDL cholesterol and their outcomes. Clin Ther. 2015;37:2751–69.CrossRefPubMed Turner T, Stein EA. Non-statin treatments for managing LDL cholesterol and their outcomes. Clin Ther. 2015;37:2751–69.CrossRefPubMed
53.
go back to reference Kingwell BA, Chapman MJ. Future of high-density lipoprotein infusion therapies: potential for clinical management of vascular disease. Circulation. 2013;128:1112–21.CrossRefPubMed Kingwell BA, Chapman MJ. Future of high-density lipoprotein infusion therapies: potential for clinical management of vascular disease. Circulation. 2013;128:1112–21.CrossRefPubMed
54.
go back to reference Zhao D, Liu J, Xie W, Qi Y. Cardiovascular risk assessment: a global perspective. Nat Rev Cardiol. 2015;12:301–11.CrossRefPubMed Zhao D, Liu J, Xie W, Qi Y. Cardiovascular risk assessment: a global perspective. Nat Rev Cardiol. 2015;12:301–11.CrossRefPubMed
55.
go back to reference Brindle PM, McConnachie A, Upton MN, Hart CL, Davey Smith G, Watt GC. The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study. Br J Gen Pract. 2005;55:838–45.PubMedPubMedCentral Brindle PM, McConnachie A, Upton MN, Hart CL, Davey Smith G, Watt GC. The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study. Br J Gen Pract. 2005;55:838–45.PubMedPubMedCentral
56.
57.
go back to reference Cheung NW, Conn JJ, d'Emden MC, Gunton JE, Jenkins AJ, Ross GP, et al. Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus. Med J Aust. 2009;191:339–44.PubMed Cheung NW, Conn JJ, d'Emden MC, Gunton JE, Jenkins AJ, Ross GP, et al. Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus. Med J Aust. 2009;191:339–44.PubMed
58.
go back to reference d'Emden MC, Shaw JE, Jones GR, Cheung NW. Guidance concerning the use of glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus. Med J Aust. 2015;203:89–90.CrossRefPubMed d'Emden MC, Shaw JE, Jones GR, Cheung NW. Guidance concerning the use of glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus. Med J Aust. 2015;203:89–90.CrossRefPubMed
59.
go back to reference Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation. 2008;118:2047–56.CrossRefPubMed Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation. 2008;118:2047–56.CrossRefPubMed
62.
64.
go back to reference Soininen P, Kangas AJ, Wurtz P, Tukiainen T, Tynkkynen T, Laatikainen R, et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst. 2009;134:1781–5.CrossRefPubMed Soininen P, Kangas AJ, Wurtz P, Tukiainen T, Tynkkynen T, Laatikainen R, et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst. 2009;134:1781–5.CrossRefPubMed
Metadata
Title
Better Indigenous Risk stratification for Cardiac Health study (BIRCH) protocol: rationale and design of a cross-sectional and prospective cohort study to identify novel cardiovascular risk indicators in Aboriginal Australian and Torres Strait Islander adults
Authors
Marc G. W. Rémond
Simon Stewart
Melinda J. Carrington
Thomas H. Marwick
Bronwyn A. Kingwell
Peter Meikle
Darren O’Brien
Nathaniel S. Marshall
Graeme P. Maguire
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2017
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-017-0662-7

Other articles of this Issue 1/2017

BMC Cardiovascular Disorders 1/2017 Go to the issue